Emerging pharmaceutical options for the treatment of individuals with presbyopia are poised to enter the eye care landscape. This novel approach represents a completely new paradigm for eye care providers to consider when discussing the array of options available with patients.
This independent educational activity is supported by an unrestricted educational grant from Allergan.
Upon completion of this activity, the participant should be able to:
Evolve Medical Education LLC (Evolve) is an approved COPE administrator.
This course is COPE approved for 1.5 hours of CE Credit for Optometrists
COPE Course #70670-PH
COPE Activity # 120865
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Recommended internet speed 5Mbps+
Milton H. Hom, OD, FAAO
Mile Brujic, OD, FAAO
Partner, Premier Vision Group
Bowling Green, Ohio
Ian Benjamin Gaddie, OD, FAAO
Owner and Director
Gaddie Eye Centers
Selina McGee, OD, FAAO
Founder Precision Vision of Edmond
Adjunct Assistant Professor
Northeastern State University College of Optometry
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Mile Brujic, OD, FAAO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of speaking, writing, participating in an advisory capacity, research or meeting support from: ABB Optical, Akorn, Alcon Laboratories, Allergan, Art Optical, Bausch + Lomb Health, Blephex, Contamac, CooperVision, CSEye, Euclid, Eyevance, Horizon Therapeutics, Johnson & Johnson Vision Care, Luneau, Novartis, Oculus, Optovue, Sight Sciences, Sun Pharma, Tangible Science, TelScreen, TruForm Optics, Valley Contax, Visionary Optics, VMax Vision, Walman Optical, Weave, Carl Zeiss Meditec, and Zea Vision.
Ian Benjamin Gaddie, OD, FAAO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Speaker’s Bureau: Aerie, Allergan, Bausch & Lomb, Ivantis, Novarris and Sight Sciences. Grant/Research Support: Aerie. Stock/Shareholder: Tarsus, and Leo Lens.
Milton M. Hom, OD, FAAO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Grant/Research Support: Allergan, Eyenovia, and Novartis. Speaker’s Bureau: Allergan.
Selina R. McGee, OD, FAAO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Cynosure, Dompe, Eyevance, Horizon, Lumenis, Novartis, Optovue, Versant, Vertical. Speaker’s Bureau: Allergan, Lumenis, and Optovue.
The Evolve Medical Education staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Allergan.